You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Phase Ib/II, open-label, dose-escalation study of LGX818, an oral selective BRAF inhibitor, in combination with MEK162, an oral MEK1/2 inhibitor, in patients with BRAF V600-dependent advanced solid tumors: preliminary results
|
|---|---|
| Published in |
Journal of Translational Medicine, May 2014
|
| DOI | 10.1186/1479-5876-12-s1-p5 |
| Authors |
Richard Kefford, Ryan J Sullivan, Wilson H Miller, Elena M Elez, Daniel Tan, Kevin B Kim, Georgina V Long, Keith T Flaherty, David Tai, Simone Stutvoet, Heiko Maacke, Matt Whiley, Laure Moutouh-de Parseval, Josep Tabernero |
Mendeley readers
The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 9 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 4 | 44% |
| Student > Ph. D. Student | 2 | 22% |
| Student > Master | 2 | 22% |
| Other | 1 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 4 | 44% |
| Agricultural and Biological Sciences | 2 | 22% |
| Economics, Econometrics and Finance | 2 | 22% |
| Biochemistry, Genetics and Molecular Biology | 1 | 11% |